Key Quantitative Figures (Amounts in ₹ Lakhs)

Quarter Ended June 30, 2026 (Unaudited)

  • Revenue from operations: 20.00
  • Other income: 0.16
  • Total income: 20.16
  • Employee benefits expense: 0.75
  • Finance Charges: 0.18
  • Other expenses: 4.78
  • Total expenses: 5.70
  • Profit/(loss) before tax: 14.46
  • Profit/(loss) for the period: 14.46
  • Total comprehensive income for the period: 14.46
  • Paid-up Equity Share Capital (Face Value of Rs. 1/- each): 477.22
  • Other Equity excluding revaluation reserves: (444.88)
  • Earnings per equity share (Basic and Diluted): 0.030

Comparative Figures

Quarter Ended March 31, 2026 (Refer Note 4)

  • Revenue from operations: 19.70
  • Profit/(loss) for the period: (27.98)
  • EPS: (0.059)

Quarter Ended June 30, 2025 (Refer Note 4)

  • Revenue from operations: 0.00
  • Profit/(loss) for the period: (2.98)
  • EPS: (0.006)

Year Ended March 31, 2026 (Audited)

  • Revenue from operations: 19.70
  • Profit/(loss) for the period: (46.06)
  • EPS: (0.097)

Board Meeting Details

  • Date: Wednesday, August 12, 2026
  • Commencement Time: 4.00 P.M.
  • Conclusion Time: 4.50 P.M.
  • Approved Items:

1. Un-Audited Financial Results (UFR) for the quarter ended June 30, 2026, along with the Statutory Auditors' Limited Review Report.

2. Reviewed the other business of the company.

Auditor's Review

  • Firm: Shah Valera & Associates LLP, Chartered Accountants (Firm Registration Number: W100238)
  • Conclusion: Based on the review conducted under SRE 2410, nothing has come to their attention that causes them to believe the Statement contains any material misstatement or has not disclosed information as required by Regulation 33.
  • Date of Report: 12 August 2026
  • Place of Signing: Mumbai

Additional Notes from Financial Statement

  • The company is engaged in a single segment: 'Trading of pharmaceuticals hygiene and cleanroom products'.
  • The company's name was changed from Kashyap Tele-Medicines Limited to June Industries Limited, effective 30th December, 2025.
  • Figures for previous periods have been re-grouped and re-arranged wherever necessary.
  • A copy of the financial results is available on the websites of BSE Limited (www.bseindia.com) and the company (www.kashyaptele-medicines.com).